HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mathilde Varret Selected Research

Mathilde Varret Research Topics

Disease

26Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2023 - 08/2002
6Cardiovascular Diseases (Cardiovascular Disease)
01/2023 - 11/2005
6Hypercholesterolemia
05/2022 - 11/2005
6Coronary Disease (Coronary Heart Disease)
12/2021 - 06/2003
5Dyslipidemias (Dyslipidemia)
12/2023 - 12/2016
3Atherosclerosis
12/2023 - 02/2015
3Familial Combined Hyperlipidemia (Combined Hyperlipidemia, Familial)
05/2022 - 01/2013
3Inborn Genetic Diseases (Disease, Hereditary)
03/2022 - 01/2003
2Stroke (Strokes)
12/2021 - 10/2018
2Thoracic Aortic Aneurysm
01/2021 - 12/2014
2Hyperlipoproteinemia Type III (Broad Beta Disease)
01/2021 - 01/2013
2Coronary Artery Disease (Coronary Atherosclerosis)
02/2015 - 03/2013
1Homozygous Familial Hypercholesterolemia
01/2023
1Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial)
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Inflammation (Inflammations)
12/2021
1Infarction (Infarctions)
12/2021
1Aortic Valve Stenosis (Aortic Stenosis)
12/2021
1Hypobetalipoproteinemias (Hypobetalipoproteinemia)
08/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Lipoprotein Glomerulopathy
01/2021
1Abetalipoproteinemia (Bassen Kornzweig Syndrome)
01/2019
1Myocardial Infarction
10/2018
1Unstable Angina
10/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Sea-Blue Histiocyte Syndrome (Sea Blue Histiocytosis)
01/2013
1Primary Hypertrophic Osteoarthropathy (Hypertrophic Osteoarthropathy, Primary)
08/2012
1Primary Myelofibrosis (Myelosclerosis)
08/2012
1Chylomicron retention disease
01/2011
1Malabsorption Syndromes (Malabsorption Syndrome)
01/2011
1Xanthomatosis (Xanthoma)
05/2010
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
04/2010
1Systemic Scleroderma (Systemic Sclerosis)
02/2009
1Genetic Predisposition to Disease (Genetic Predisposition)
02/2009
1Marfan Syndrome (Marfan's Syndrome)
08/2004
1Neoplasms (Cancer)
08/2004
13 Autosomal Dominant Hypercholesterolemia
06/2003

Drug/Important Bio-Agent (IBA)

13Apolipoproteins B (ApoB)IBA
01/2023 - 01/2003
13LDL CholesterolIBA
01/2023 - 06/2003
11LDL Receptors (LDL Receptor)IBA
09/2023 - 08/2002
11ApolipoproteinsIBA
08/2021 - 01/2003
10Proprotein Convertase 9IBA
09/2023 - 06/2003
8CholesterolIBA
12/2021 - 11/2005
7Apolipoproteins E (ApoE)IBA
12/2023 - 01/2013
7oxidized low density lipoproteinIBA
09/2023 - 11/2005
6LDL Lipoproteins (beta Lipoproteins)IBA
03/2013 - 04/2009
5LipidsIBA
01/2023 - 01/2011
5Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA
12/2016 - 07/2009
4Triglycerides (Triacylglycerol)IBA
05/2022 - 01/2013
4SubtilisinIBA
12/2016 - 11/2010
3Lipoproteins (Lipoprotein)IBA
01/2022 - 01/2019
21,3,4,6- tetra- O- acetyl- 2- azido- 2- deoxyglucopyranose (TAAD)IBA
01/2021 - 12/2014
2ProstaglandinsIBA
01/2021 - 08/2012
2Proteins (Proteins, Gene)FDA Link
01/2021 - 01/2011
2Apolipoprotein B-100 (Apo B 100)IBA
12/2012 - 05/2012
2LigandsIBA
07/2009 - 04/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2023
1ChylomicronsIBA
01/2022
1Streptozocin (Streptozotocin)FDA Link
12/2021
1Antifibrinolytic Agents (Antifibrinolytics)IBA
12/2021
1Lipoprotein(a)IBA
12/2021
1Ephrin-B2 (Ephrin B2)IBA
12/2021
1Apolipoprotein E2IBA
01/2021
1Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2021
1Prostaglandin D2IBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1O(4)-methylthymidine triphosphateIBA
01/2019
1microsomal triglyceride transfer proteinIBA
01/2019
1AntibodiesIBA
10/2017
1PCSK9 InhibitorsIBA
12/2016
1Fibrillin-1IBA
04/2010
1subtilinIBA
07/2009
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
02/2009
1F 382IBA
11/2005
1Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
08/2004
1Transforming Growth Factor-beta Type II ReceptorIBA
08/2004
1FibrillinsIBA
08/2004

Therapy/Procedure

2Therapeutics
10/2017 - 12/2016
1Bariatric Surgery
01/2022
1Electrocoagulation (Electrocautery)
12/2021
1Percutaneous Coronary Intervention
10/2018